tradingkey.logo
tradingkey.logo

Heartflow Inc

HTFL
24.690USD
-1.190-4.60%
Fechamento 03/27, 16:00ETCotações atrasadas em 15 min
1.99BValor de mercado
PerdaP/L TTM

Mais detalhes de Heartflow Inc Empresa

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Informações de Heartflow Inc

Código da empresaHTFL
Nome da EmpresaHeartflow Inc
Data de listagemAug 08, 2025
CEOFarquhar (John C. M)
Número de funcionários699
Tipo de títulosOrdinary Share
Fim do ano fiscalAug 08
Endereço331 E Evelyn Avenue
CidadeMOUNTAIN VIEW
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94041
Telefone16502411221
Sitehttps://www.heartflow.com/
Código da empresaHTFL
Data de listagemAug 08, 2025
CEOFarquhar (John C. M)

Executivos da empresa Heartflow Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
191.81K
+35.43%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
--
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Mr. John C. M. Farquhar
Mr. John C. M. Farquhar
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Julie Cullivan
Ms. Julie Cullivan
Independent Director
Independent Director
--
--
Mr. Tim Barabe
Mr. Tim Barabe
Independent Director
Independent Director
--
--
Dr. Wayne Riley, M.D.
Dr. Wayne Riley, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Vikram Verghese
Mr. Vikram Verghese
Chief Financial Officer
Chief Financial Officer
191.81K
+35.43%
Mr. Jeffrey C. Lightcap
Mr. Jeffrey C. Lightcap
Independent Director
Independent Director
40.00K
--
Mr. Lonnie M. Smith
Mr. Lonnie M. Smith
Independent Director
Independent Director
34.25K
--
Mr. Casey M. Tansey
Mr. Casey M. Tansey
Independent Director
Independent Director
16.45K
--
Dr. Charles A. Taylor, Ph.D.
Dr. Charles A. Taylor, Ph.D.
Director
Director
--
--
Dr. Campbell D. Rogers, M.D.
Dr. Campbell D. Rogers, M.D.
Chief Medical Officer
Chief Medical Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United states
42.95M
92.80%
United kingdom
1.52M
3.28%
Japan
1.46M
3.16%
Rest of europe
349.00K
0.75%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.

Distribuição de ações

Atualizado em: qui, 19 de fev
Atualizado em: qui, 19 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Wellington Management Company, LLP
13.90%
Bain Capital Life Sciences Investors, LLC
12.18%
HealthCor Partners Management LP
7.81%
Fidelity Management & Research Company LLC
4.69%
Hayfin Capital Management LLP
4.24%
Outro
57.18%
Investidores
Investidores
Proporção
Wellington Management Company, LLP
13.90%
Bain Capital Life Sciences Investors, LLC
12.18%
HealthCor Partners Management LP
7.81%
Fidelity Management & Research Company LLC
4.69%
Hayfin Capital Management LLP
4.24%
Outro
57.18%
Tipos de investidores
Investidores
Proporção
Investment Advisor
48.61%
Investment Advisor/Hedge Fund
23.88%
Hedge Fund
4.68%
Individual Investor
2.77%
Bank and Trust
0.41%
Endowment Fund
0.36%
Research Firm
0.30%
Venture Capital
0.18%
Sovereign Wealth Fund
0.04%
Outro
18.77%

Participação acionária institucional

Atualizado em: qua, 21 de jan
Atualizado em: qua, 21 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q4
129
59.51M
43.48%
--
2025Q4
157
60.44M
71.29%
+22.15M
2025Q3
46
45.42M
54.46%
+42.91M

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Wellington Management Company, LLP
4.88M
5.73%
+465.57K
+10.55%
Sep 30, 2025
Bain Capital Life Sciences Investors, LLC
12.45M
14.62%
--
--
Sep 30, 2025
HealthCor Partners Management LP
6.70M
7.86%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.62M
5.42%
+1.33M
+40.42%
Sep 30, 2025
Hayfin Capital Management LLP
3.64M
4.27%
-1.00
-0.00%
Sep 30, 2025
Baillie Gifford & Co.
3.01M
3.53%
+415.89K
+16.06%
Sep 30, 2025
Baron Capital Management, Inc.
1.24M
1.45%
+1.24M
--
Sep 30, 2025
Schusterman Interests LLC
1.94M
2.28%
+1.94M
--
Sep 30, 2025
Capricorn Investment Group LLC
3.92M
4.61%
+3.92M
--
Aug 08, 2025
The Vanguard Group, Inc.
1.45M
1.7%
+285.27K
+24.45%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
TrueShares Technology, AI & Deep Learning ETF
3.13%
Global X HealthTech ETF
1.75%
Fidelity Blue Chip Growth ETF
0.07%
T Rowe Price Small-Mid Cap ETF
0.06%
iShares Health Innovation Active ETF
0.02%
Schwab U.S. Small-Cap ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Schwab U.S. Broad Market ETF
0%
TrueShares Technology, AI & Deep Learning ETF
Proporção3.13%
Global X HealthTech ETF
Proporção1.75%
Fidelity Blue Chip Growth ETF
Proporção0.07%
T Rowe Price Small-Mid Cap ETF
Proporção0.06%
iShares Health Innovation Active ETF
Proporção0.02%
Schwab U.S. Small-Cap ETF
Proporção0.02%
Fidelity Nasdaq Composite Index ETF
Proporção0.01%
Schwab U.S. Broad Market ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
KeyAI